Back to search

University of Thessaly (UTH)

Διερεύνηση της επίδρασης της προεγχειρητικής χορήγησης ερυθρομυκίνης στη γνωσιακή λειτουργία, στη διεγχειρητική εγκεφαλική οξυμετρία και σε βιοχημικούς δείκτες ισχαιμίας και φλεγμονής σε καρδιοχειρουργικούς ασθενείς

Abstract

dc:description

BACKGROUND: Postoperative cognitive decline and co-existing brain damage usually complicate cardiothoracic patients after surgery. This study investigated if patients could benefit from the perioperative administration of erythromycin and the intraoperative use of cerebral oximetry, concerning postoperative cognitive decline (POCD) and neurologic deficit.METHODS: The study concluded forty patients scheduled for elective coronary artery bypass grafting (CABG) surgery. They were prospectively randomly assigned in two groups: the erythromycin group (n=19) and the control group (n=21). Patients from the erythromycin group received erythromycin at a dose of 25 mg/kg 12h before and 12h after surgery and patients from the control group received placebo at the same time points. Near-infrared spectroscopy (NIRS) technology was performed to all patients intraoperatively and cerebral desaturation events (DE) were recorded. As an index of cerebral damage, Τau protein serum levels were measured perioperatively, before and after surgery. All patients were assessed by an experienced neuropsychologist at three time points: before surgery, on the day of discharge and 3 months later. RESULTS: Patients from both groups were comparable regarding demographic and clinical data. The neurocognitive assessment of the erythromycin group revealed significantly better results from the placebo group, both prior to discharge (p=0.001) and 3 months postoperatively (p=0.01). After surgery, in the control group, tau protein levels were significantly raised (p=0.02), while in the erythromycin group, Tau protein was slightly increased.No statistical significant differences were found between groups as far as DE events were concerned. However, after discharge, in the control group, all patients with DE (100%) presented POCD, while ιn the erythromycin group only half (50%) of the patients with DE presented POCD after surgery (p=0.01). Three months after surgery, in the control group, 80% of the patients with DE presented POCD, while in the erythromycin group only 30% of the patients with DE did so (p=0.02).CONCLUSIONS: Brain injury and neurocognitive dysfunction could be attenuated by erythromycin administration and patients could benefit from the intraoperative use of NIRS technology. Tau protein may be used for cerebral damage estimation and monitoring perioperatively.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Thomaidou, Evanthia
  • Θωμαΐδου, Ευανθία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43151

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Thomaidou, Evanthia; Θωμαΐδου, Ευανθία. Διερεύνηση της επίδρασης της προεγχειρητικής χορήγησης ερυθρομυκίνης στη γνωσιακή λειτουργία, στη διεγχειρητική εγκεφαλική οξυμετρία και σε βιοχημικούς δείκτες ισχαιμίας και φλεγμονής σε καρδιοχειρουργικούς ασθενείς. University of Thessaly (UTH), 2018. http://hdl.handle.net/10442/hedi/43151